• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

MMA Payout

The Business of Combat Sports

  • Home
  • MMA
    • UFC
    • Bellator
    • One
    • PFL
  • Boxing
  • Legal
  • Ratings
  • Payouts
  • Attendance
  • Gate

USADA issues 2 year ban for UFC light heavyweight

July 9, 2019 by Jason Cruz Leave a Comment

Former UFC light heavyweight Ivan Shtyrkov has accepted a two-year suspension from USADA for violation of the UFC anti-doping rules.  The Russian stated on social media that he tested positive for a banned substance and this was confirmed by USADA on Tuesday.

Despite accepting the suspension, Shtyrkov has signed with Rizin FF.

Shtyrkov accepted a fight against Devin Clark at UFC on ESPN +7 this past March but that fight was scrapped after USADA notified the UFC that two out-of-competition urine samples had returned an “atypical” result.  The samples contained the banned steroid boldenone and its metabolite 5β-androst-1-en-17β-ol-3-one.  Boldenone is a veterinarian drug used on horses but has been used by professional athletes.  Notably, Stephan Bonnar and Josh Barnett had tested positive for the banned substance.

Boldenone is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List.

Shtyrkov is undefeated with 16 wins and one draw.  It was initially announced that he was “sick” and hospitalized as a reason from pulling out of his fight with Devin Clark.   Shtyrkov’s manager indicated that a USADA test came back with an abnormal reading and not a positive test for PEDs.

Payout Perspective: 

 Here’s a case where you can argue that the USADA tests were not conclusive for the banned substance.  Yet, evidence was clear enough to pull him from his UFC debut and we are brought back to the argument about how long a substance can remain in one’s system.  We’ve seen this with Jon Jones and this may have been another case.  Despite the ban, Shtyrkov has decided to continue his career with Rizin.

Filed Under: Drug Testing, Flagged by USADA, UFC, USADA

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Featured

UFC Freedom 250 kits revealed

Dominance responds to Plaintiffs’ Fee Request

Senate makes mockery of Ali Act hearing

Wrestlemania 42 attendance dips from 2025

How will WWE’s big weekend turn out?

UFC 327 attendance, gate and bonuses

Archives

MMA Payout Follow

MMAPayout

UFC Freedom 250 kits revealed https://mmapayout.com/2026/05/11/ufc-freedom-250-kits-revealed/

Unpopular opinion: Kevin Harlan just yells #NBA #Lakers #FOKC

Marcus Smart with a play #Lakers

The guy sold the team to OKC claiming they’d build something in Seattle

Wall Street Journal Opinion @WSJopinion

Seattle turns hostile to the great businesses it made. Starbucks is moving jobs from Washington state to Tennessee, and it isn’t alone in looking elsewhere, writes @HowardSchultz
https://on.wsj.com/4uCiVCD

Retweet on Twitter MMA Payout Retweeted

How did Loeffler/360 Promotions rebuild interest in Bohachuk after he lost to Adams the first time?
Why does any promoter, if they still have the rights to the fighter, continue their agreement after a loss?
An attorney and former boxing manager's thoughts (archived):

Load More

Copyright © 2026 · MMA Payout: The Business of Combat Sports